Boston Scientific stock fell 8.4% despite beating Q4 earnings as weak Q1 guidance and electrophysiology division miss disappointed investors.
Original Image Link
Source:blockonomi.com
Original Image Link
Source:blockonomi.com
Posted: 2026-02-04 06:04:00

















